HI
EVFM

Harbour Investments’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Harbour Investments’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8
Closed – – 3985
2021
Q3 		$0 Hold
8
– – ﹤0.01% 4118
2021
Q2 		$0 Hold
8
– – ﹤0.01% 4057
2021
Q1 		$0 Buy
+8
New +$364 ﹤0.01% 3784

Other funds holding EVFM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Harbour Investments's EVFM Position: Q4 2021 in Review

Harbour Investments sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q4 2021, closing a stake of 8 shares.

Harbour Investments first reported a position in EVFM in Q1 2021 and held it in 3 quarters. The position peaked at $0 in Q3 2021. 62 funds tracked by Wall St. Rank hold EVFM as of Q4 2021.

  • Harbour Investments reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Harbour Investments sold 8 Evofem Biosciences, Inc. Common Stock shares in Q4 2021.
  • Harbour Investments first reported a position in Evofem Biosciences, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Harbour Investments's Evofem Biosciences, Inc. Common Stock position peaked at $0 in Q3 2021.
  • 62 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2021.

Based on Harbour Investments's 13F filing for Q4 2021, filed 16 Feb 2022.